Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

A Systematic Review of Molecular Hydrogen Therapy in Cancer Management

Research hubs: Immune System

Scientific visualization of hydrogen therapy research for A Systematic Review of Molecular Hydrogen Therapy in Cancer Management
Evidence type
Systematic review or meta-analysis
Authors
Muhammad Nooraiman Zufayri Mohd Noor, Adlin Sofea Alauddin, Yin How Wong, Chung Yeng Looi, Eng Hwa Wong, Priya Madhavan, Chai Hong Yeong
Journal
Asian Pacific Journal of Cancer Prevention
Year
2023
Study Type
clinical
Delivery
mixed
Outcome
positive
Peer Reviewed
Yes
Cited by
34 (OpenAlex, as of November 2026)
Country
Malaysia

TL;DR

Scientists looked at studies about a gas called molecular hydrogen (H2) and found it might help cancer patients feel better and live longer when used alongside regular cancer treatments. While the results look really promising, doctors need to do more research before they can officially recommend it as part of cancer care.

Key Finding

Multiple studies suggest molecular hydrogen may help improve survival, quality of life, and tumor reduction when used alongside or as a complement to conventional cancer treatments, though comprehensive clinical trials are still needed.

Summary

This review examined 27 studies on molecular hydrogen (H2), a gas that has been tested as a potential helper treatment alongside standard cancer therapies. Researchers found that across different types of cancer and ways of delivering hydrogen, the studies consistently reported improvements in survival rates, quality of life, blood markers, and tumor shrinkage. However, the authors note that larger, more rigorous studies are needed before hydrogen can be recommended as a standard cancer treatment.

Practical Takeaway

While this review identifies encouraging patterns across existing research, most studies appear to be small or conducted in laboratory or animal settings rather than large human trials. Anyone with cancer interested in hydrogen therapy should discuss it with their oncologist, as the evidence is still preliminary and not yet strong enough to replace standard treatments.

Abstract (excerpt)

Background: Cancer remains a challenging target to cure, with present therapeutic methods unable to exhibit restorative outcomes without causing severe negative effects. Molecular hydrogen (H2) has been reported to be a promising adjunctive therapy for cancer treatment, having the capability…

Read the full abstract on PubMed